However, a tendency of higher percentage of double-positive IFN-γ+IL-17+ T cells was found in the MS cohort (p = 0.0734) vs HIMS at day 10 (Fig 2G and 2H). The gene discussed is IL17A; the disease is myeloid sarcoma.